Cargando…
In Vitro Investigation of Auranofin as a Treatment for Clostridium difficile Infection
BACKGROUND: Clostridium difficile infection is the leading cause of hospital-acquired gastrointestinal infection and incidence rates continue to rise. Clostridium difficile infection is becoming increasingly complex to treat owing to the rise in treatment failures and recurrent infections. There is...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419417/ https://www.ncbi.nlm.nih.gov/pubmed/32377889 http://dx.doi.org/10.1007/s40268-020-00306-3 |